Avid Bioservices Inc (CDMO)

[Frustrated]

Pretty damaging stuff if true.

CW No. 3 believes, based on his experience at
Peregrine and the flurry of activity following the Abbvie on-site audit of Peregrine,
that it was Abbvie who discovered the “major discrepancies” in the data from the
results of the prior P-K testing performed at Peregrine. Abbvie then soured on a
partnership when Peregrine admitted that its prior statements about the results of the
data were false and misleading.
136. CW3 also confirmed that Defendant King flew to Chicago to meet with
representatives of Abbvie in an effort to keep them interested in a partnership with
Peregrine, but to no avail.
137. Upon information and belief, CW3 believes that Abbvie refused to do
business with a company or its executives who would be deliberately reckless in
releasing statements about the positive nature of clinical data before verifying the
accuracy of the data or the truth and accuracy of their own statements or who even
failed to verify which patients received which substance, placebo or bavituximab.